HB 1236 adds tetrahydrocannabinol (THC)—the active compound in cannabis—to South Dakota's industrial hemp regulations to allow its use for medical purposes. The bill modifies the state's hemp definitions and licensing rules under the Department of Agriculture and Natural Resources to accommodate medical THC products that may exceed the current 0.3% THC limit for regular industrial hemp. This creates a regulatory pathway for producing and using THC-based medicines in South Dakota.
State Affairs Tabled Passed, YEAS 10, NAYS 0.
State Affairs Scheduled for hearing H.J. 1
First read in House and referred to House State Affairs H.J. 196
Sue Peterson
Prime sponsor · Rep.
R
State Affairs — Tabled